68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report

被引：154
|
作者：
Rauscher, Isabel [1 ,2 ,3 ]
Maurer, Tobias [2 ,4 ]
Fendler, Wolfgang P. [2 ,5 ]
Sommer, Wieland H. [2 ,6 ]
Schwaiger, Markus [1 ,2 ,3 ]
Eiber, Matthias [1 ,2 ,3 ]
机构：
[1] Tech Univ Munich, Dept Nucl Med, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[2] Clin Canc Ctr Munich CCM, Munich, Germany
[3] German Canc Consortium DKTK, Heidelberg, Germany
[4] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[5] Univ Munich, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[6] Univ Munich, Dept Clin Radiol, Grosshadern Campus,Marchioninistr 15, D-81377 Munich, Germany
来源：
CANCER IMAGING | 2016年 / 16卷
关键词：
Prostate cancer; Prostate specific membrane antigen; Positron emission tomography; GA-68-LABELED PSMA LIGAND; MEMBRANE ANTIGEN; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; LYMPH-NODES; HBED-CC; DIAGNOSIS; EXPRESSION; CARCINOMA; TOMOGRAPHY;
D O I：
10.1186/s40644-016-0072-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recently, positron emission tomography (PET) imaging using PSMA-ligands has gained high attention as a promising new radiotracer in patients with prostate cancer (PC). Several studies promise accurate staging of primary prostate cancer and restaging after biochemical recurrence with Ga-68-PSMA ligand Positron emission tomography/computed tomography (PET/CT). However, prospective trials and clinical guidelines for this new technique are still missing. Therefore, we summarized our experience with Ga-68-PSMA ligand PET/CT examinations in patients with primary PC and biochemical recurrence. It focuses on the technical and logistical aspects of Ga-68-PSMA ligand PET/CT examination as well as on the specific background for image reading discussing also potential pitfalls. Further, it includes relevant issues on free-text as well as structured reporting used in daily clinical routine.
引用
收藏
页数：10
相关论文
共 50 条
  • [1] 68Ga-PSMA ligand PET/CT in patients with prostate cancer: How we review and report
    Isabel Rauscher
    Tobias Maurer
    Wolfgang P. Fendler
    Wieland H. Sommer
    Markus Schwaiger
    Matthias Eiber
    Cancer Imaging, 16
  • [2] 68Ga-PSMA PET/CT in prostate cancer
    Garcia Garzon, J. R.
    de Arcocha Torres, M.
    Delgado-Bolton, R.
    Ceci, F.
    Alvarez Ruiz, S.
    Orcajo Rincon, J.
    Caresia Aroztegui, A. P.
    Garcia Velloso, M. J.
    Garcia Vicente, A. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138
  • [3] The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    UROLOGY, 2019, 130 : 1 - 12
  • [4] 68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients
    Sanli, Yasemin
    Sanli, Oner
    Simsek, Duygu Has
    Subramaniam, Rathan M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (10) : 871 - 880
  • [5] 68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients
    Caroli, Paola
    Sandler, Israel
    Matteucci, Federica
    De Giorgi, Ugo
    Uccelli, Licia
    Celli, Monica
    Foca, Flavia
    Barone, Domenico
    Romeo, Antonino
    Sarnelli, Anna
    Paganelli, Giovanni
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (12) : 2035 - 2044
  • [6] Detection Rate of 68Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy
    Brumberg, Joachim
    Beckl, Melanie
    Dierks, Alexander
    Schirbel, Andreas
    Krebs, Markus
    Buck, Andreas
    Kuebler, Hubert
    Lapa, Constantin
    Seitz, Anna Katharina
    BIOMEDICINES, 2020, 8 (11) : 1 - 11
  • [7] Evaluation of 68Ga-PSMA PET/CT with volumetric parameters for staging of prostate cancer patients
    Aksu, Aysegul
    Karahan Sen, Nazli Pinar
    Tuna, Emine Burcin
    Aslan, Guven
    Capa Kaya, Gamze
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (05) : 503 - 509
  • [8] Impact of 68Ga-PSMA PET/CT on radiation treatment planning of prostate cancer patients
    Bock, Felix
    Frerker, Bernd
    Schubert, Laura
    Rennau, Hannes
    Kurth, Jens
    Krause, Bernd J.
    Hildebrandt, Guido
    Schwarzenboeck, Sarah Marie
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2024, 63 (03): : 199 - 206
  • [9] 68Ga-PSMA PET/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature
    Zacho, Helle D.
    Nielsen, Julie B.
    Haberkorn, Uwe
    Stenholt, Louise
    Petersen, Lars J.
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2018, 38 (06) : 911 - 922
  • [10] 68Ga-PSMA PET/CT for the evaluation of metastasis in patients with prostate cancer: A systematic review and meta-analysis
    Zhou, Jing
    Wu, Renhui
    Wang, Wenrong
    Zhao, Yigang
    Liu, Xiaohua
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 297 - 311
12345